Resources for Food and Drug Administration (FDA)

FDA Halts New Applications From Indian Drug Maker's Plant

health.usnews.com

U.S. health officials have halted the review of any new drug applications from a Ranbaxy Laboratories plant in India after determining the facility was falsifying scientific data.Ranbaxy, based in India, is one of the largest suppliers of generic drugs to the United States. "We took this action after it became apparent that this facility was submitting falsified scientific data in applications for FDA approval of marketed drugs in the United States," Dr. Douglas Throckmorton, deputy director of FDA's Center for Drug Evaluation and Research, said during a Wednesday teleconference.

View the Resource

Share or bookmarklet this web page at: